TTY Biopharm Company Limited was established in 1960. For more than fifty years, TTY Biopharm has transformed from a production and sales oriented traditional generic drug pharmaceutical factory into development and marketing of branded generic drugs. With unending self-renovation and transformation, we utilize the experience, technology, and relationship network accumulated over the decades to seek improvement. Nowadays, we redefine ourselves as a biotech company focusing on developing special formulations and new drugs. We hope to achieve our enterprise vision of “improving the quality of human life with scientific innovation.”
The journey has seen our active expansion into promising markets across the world – from our base in Europe, to the Middle East & Africa, through to the Far East and the Americas. Outside our 21 core offices, we developed a network of trusted agents and partners allowing us to operate in 107 countries.
Today, Medochemie Ltd has thirteen manufacturing plants and facilities. Nine are in Cyprus, one in the Netherlands, and three in Vietnam. We have acquired and maintain 4,355 marketing authorisation licences for 630 different pharmaceutical products, classified in over 10 therapeutic categories. We operate in accordance with the strictest quality standards and in full compliance with European guidelines.
The driving force behind Medochemie is our 1880 multinational, talented, quality-focused employees, who work in our manufacturing plants and offices worldwide.
Medochemie is a founding member of the Medicines for Europe (former EGA).
Alpex Pharma is a pharmaceutical company active in Research & Development and Production of ODT (Orally Dispersible Tablet) called also “fast melt” and effervescent tablets. Alpex Pharma has developed a unique proprietary covering ODT technology.
The high production capacity and advanced R&D technologies makes Alpex Pharma to be one of the most important company of the world in the field of fast melt and effervescent tablets.
The company has a state-of-the-art manufacturing and R&D facilities of some 7000 square meters, with separate pharmaceutical and nutritional plant GMP compliant.
ANFARM Hellas SA, an EU GMP Pharmaceuticals’ Manufacturer, was established in 1967 by its founder and president Mr. Apostolos Nicolaou with the vision to provide quality generic pharmaceuticals to every country in the world.
Today, ANFARM, is a highly reputable manufacturer of generic pharmaceuticals with an extended export activity worldwide, through licensing, direct exports and as a third party manufacturer.